GlobeNewswire 2021-04-26 Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeS...
GlobeNewswire 2021-04-05 Precipio Enters Into an At-The -Market (ATM) Financing Arrangement
GlobeNewswire 2021-03-30 Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY
GlobeNewswire 2021-03-03 Mr. Ron Andrews joins Precipio’s Board of Directors
GlobeNewswire 2021-03-03 Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
GlobeNewswire 2021-01-28 Precipio Launches COVID-19 Antibody Testing at Point-of-Care
GlobeNewswire 2021-01-20 Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
GlobeNewswire 2020-12-10 Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor
GlobeNewswire 2020-10-06 Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
GlobeNewswire 2020-09-22 Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel
GlobeNewswire 2020-09-04 Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans
GlobeNewswire 2020-08-20 Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™
GlobeNewswire 2020-08-04 Precipio Launches Covid-19 Antibody Test in its CLIA laboratory
GlobeNewswire 2020-07-30 Precipio Announces Commercial Launch of COVID-19 Antibody Test
GlobeNewswire 2020-07-22 Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’...
GlobeNewswire 2020-07-01 Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement
GlobeNewswire 2020-03-20 Company Update During the COVID-19 Era
GlobeNewswire 2020-03-16 Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
GlobeNewswire 2020-02-18 Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnershi...
GlobeNewswire 2020-01-28 Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing
GlobeNewswire 2019-09-26 Clinical Validations for IV-Cell™ and HemeScreen™ Completed
GlobeNewswire 2019-09-05 Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagn...
GlobeNewswire 2019-06-17 Precipio CEO Provides Update Letter To Shareholders
GlobeNewswire 2019-06-04 Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
GlobeNewswire 2019-05-23 Precipio CEO enrolls in long term stock purchase plan